vs
MYRIAD GENETICS INC（MYGN）与TRINITY BIOTECH PLC（TRIB）财务数据对比。点击上方公司名可切换其他公司
MYRIAD GENETICS INC的季度营收约是TRINITY BIOTECH PLC的6.9倍（$209.8M vs $30.5M）
麦利亚德基因公司是总部位于美国犹他州盐湖城的美国基因检测与精准医疗企业。公司拥有多项自主专利技术，帮助医生与患者了解人类疾病的遗传基础，以及基因在疾病发生、发展和治疗中发挥的作用，相关成果可用于开发评估患病风险、指导疾病诊疗的新产品。
Trinity Biotech PLC是一家全球体外诊断企业，研发、生产和销售适用于临床实验室与床旁检测场景的诊断试剂盒及配套系统，产品线覆盖糖尿病管理、传染病、心脏健康、自身免疫疾病等领域，主要市场包括北美、欧洲及全球新兴经济体。
MYGN vs TRIB — 直观对比
营收规模更大
MYGN
是对方的6.9倍
$30.5M
损益表 — Q4 2025 vs Q2 2024
| 指标 | | |
|---|---|---|
| 营收 | $209.8M | $30.5M |
| 净利润 | — | $-10.1M |
| 毛利率 | 70.0% | 36.8% |
| 营业利润率 | -2.7% | -23.2% |
| 净利率 | — | -33.0% |
| 营收同比 | -0.4% | — |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $-0.09 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MYGNTRIB
| Q4 25 | $209.8M | — | ||
| Q3 25 | $205.7M | — | ||
| Q2 25 | $213.1M | — | ||
| Q1 25 | $195.9M | — | ||
| Q4 24 | $210.6M | — | ||
| Q3 24 | $213.3M | — | ||
| Q2 24 | $211.5M | $30.5M | ||
| Q1 24 | $202.2M | — |
净利润MYGNTRIB
| Q4 25 | — | — | ||
| Q3 25 | $-27.4M | — | ||
| Q2 25 | $-330.5M | — | ||
| Q1 25 | $-100.0K | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-22.1M | — | ||
| Q2 24 | $-36.7M | $-10.1M | ||
| Q1 24 | $-26.0M | — |
毛利率MYGNTRIB
| Q4 25 | 70.0% | — | ||
| Q3 25 | 69.9% | — | ||
| Q2 25 | 71.2% | — | ||
| Q1 25 | 68.5% | — | ||
| Q4 24 | 71.7% | — | ||
| Q3 24 | 70.2% | — | ||
| Q2 24 | 69.6% | 36.8% | ||
| Q1 24 | 68.1% | — |
营业利润率MYGNTRIB
| Q4 25 | -2.7% | — | ||
| Q3 25 | -11.3% | — | ||
| Q2 25 | -154.5% | — | ||
| Q1 25 | -14.8% | — | ||
| Q4 24 | -18.6% | — | ||
| Q3 24 | -9.4% | — | ||
| Q2 24 | -17.3% | -23.2% | ||
| Q1 24 | -13.8% | — |
净利率MYGNTRIB
| Q4 25 | — | — | ||
| Q3 25 | -13.3% | — | ||
| Q2 25 | -155.1% | — | ||
| Q1 25 | -0.1% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -10.4% | — | ||
| Q2 24 | -17.4% | -33.0% | ||
| Q1 24 | -12.9% | — |
每股收益（稀释后）MYGNTRIB
| Q4 25 | $-0.09 | — | ||
| Q3 25 | $-0.29 | — | ||
| Q2 25 | $-3.57 | — | ||
| Q1 25 | $0.00 | — | ||
| Q4 24 | $-0.47 | — | ||
| Q3 24 | $-0.24 | — | ||
| Q2 24 | $-0.41 | — | ||
| Q1 24 | $-0.29 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $149.6M | $5.3M |
| 总债务越低越好 | $119.9M | — |
| 股东权益账面价值 | $368.0M | $-29.4M |
| 总资产 | $706.6M | $94.4M |
| 负债/权益比越低杠杆越低 | 0.33× | — |
8季度趋势，按日历期对齐
现金及短期投资MYGNTRIB
| Q4 25 | $149.6M | — | ||
| Q3 25 | $145.4M | — | ||
| Q2 25 | $74.4M | — | ||
| Q1 25 | $91.8M | — | ||
| Q4 24 | $102.4M | — | ||
| Q3 24 | $99.9M | — | ||
| Q2 24 | $97.3M | $5.3M | ||
| Q1 24 | $104.3M | — |
总债务MYGNTRIB
| Q4 25 | $119.9M | — | ||
| Q3 25 | $119.5M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益MYGNTRIB
| Q4 25 | $368.0M | — | ||
| Q3 25 | $372.8M | — | ||
| Q2 25 | $388.1M | — | ||
| Q1 25 | $704.9M | — | ||
| Q4 24 | $701.1M | — | ||
| Q3 24 | $731.7M | — | ||
| Q2 24 | $740.5M | $-29.4M | ||
| Q1 24 | $760.0M | — |
总资产MYGNTRIB
| Q4 25 | $706.6M | — | ||
| Q3 25 | $728.1M | — | ||
| Q2 25 | $677.3M | — | ||
| Q1 25 | $1.0B | — | ||
| Q4 24 | $1.0B | — | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.1B | $94.4M | ||
| Q1 24 | $1.1B | — |
负债/权益比MYGNTRIB
| Q4 25 | 0.33× | — | ||
| Q3 25 | 0.32× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $10.6M | $-3.9M |
| 自由现金流经营现金流 - 资本支出 | — | $-4.1M |
| 自由现金流率自由现金流/营收 | — | -13.3% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-4.1M |
8季度趋势，按日历期对齐
经营现金流MYGNTRIB
| Q4 25 | $10.6M | — | ||
| Q3 25 | $21.1M | — | ||
| Q2 25 | $-13.6M | — | ||
| Q1 25 | $-16.3M | — | ||
| Q4 24 | $6.6M | — | ||
| Q3 24 | $700.0K | — | ||
| Q2 24 | $2.6M | $-3.9M | ||
| Q1 24 | $-18.6M | — |
自由现金流MYGNTRIB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-4.1M | ||
| Q1 24 | — | — |
自由现金流率MYGNTRIB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -13.3% | ||
| Q1 24 | — | — |
资本支出强度MYGNTRIB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.5% | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
